Contracts › 75F40126C00019
75F40126C00019: Proposed Research Qualifies As Development (Per Its Definition in Far 35.001) As Primary Focus of the Proposed Project Is on Developing a Digital Twin Model, for Evaluation of Breast Cancer Imaging Modalities.
Awarded to Malcova Inc by Food and Drug Administration (FDA).
$1.0Mobligated
$1.0Mpotential value
07 June 2027current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75F40126C00019 |
|---|---|
| Awardee | Malcova Inc |
| Awarding agency | Food and Drug Administration (FDA) |
| Awarding office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) |
| PSC | AJ12 General Science and Technology R&D Services; General Science and Technology; Applied Research |
| Place of performance | CA |
| Offers received | 1 |
| Period of performance | 08 June 2026 to 07 June 2027 |
| Potential end | 07 June 2027 |
| Estimated recompete solicitation | ~Q4 2026 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541715 contracts · All expiring contracts · USASpending record